Hemostasis after abdominal wall surgery with 4DryField® PH

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

DRKS

Registry ID

DRKS00012547

Enrollment

Registered

2018-01-05

Start date

2016-07-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound healing disorder Sermon T81.0 T81.4

Interventions

Group 1: A concluding large-scale hemostasis with 4DryField® PH is performed. Group 2: No concluding large-scale hemostasis is performed.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Written consent to participate in the study, 2. Anterior abdominoplasty or lower Bodylift after Lockwood

Exclusion criteria

Exclusion criteria: 1. Less extensive surgical procedure, 2. Intolerance to starch

Design outcomes

Primary

Measure	Time frame
Postoperative blood loss, measured as total volume of the drainages until the drainage is removed	—

Secondary

Measure	Time frame
1. Fraction of patients with wound infections, 2. Fraction of patients with seromas, 3. Fraction of patients with wound healing disturbances (Appearances are recorded up to the end of the studies)	—

Countries

Germany

Contacts

Public ContactMona Rudolph

Asklepios Klinikum Wandsbek - Abteilung für Plastische und Ästhetische Chirurgie

mo.rudolph@asklepios.com+49 – 40 - 1818831320

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026